Oxidative stress and neurodegeneration

被引:133
作者
Moreira, PI
Smith, MA
Zhu, XW
Nunomura, A
Castellani, RJ
Perry, G
机构
[1] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
[2] Univ Coimbra, Ctr Neurosci & Cell Biol Coimbra, P-3004517 Coimbra, Portugal
[3] Asahikawa Med Coll, Dept Psychiat & Neurol, Asahikawa, Hokkaido 0788510, Japan
[4] Michigan State Univ, Dept Physiol Neuropathol, E Lansing, MI 48823 USA
来源
MAILLARD REACTION: CHEMISTRY AT THE INTERFACE OF NUTRITION, AGING, AND DISEASE | 2005年 / 1043卷
关键词
advanced glycation end products; Alzheimer's disease; oxidative stress; neurofibrillary tangles; senile plaques;
D O I
10.1196/annals.1333.062
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oxidative stress is a well-studied early response in chronic neurodegenerative diseases, including Alzheimer's disease, where neuronal loss can exceed 90% in the vulnerable neuronal population. Oxidative stress affects all classes of macromolecules (sugar, lipids, proteins, and DNA), leading inevitably to neuronal dysfunction. We observed that N-(carboxymethyl)lysine (CML), the predominant advanced glycation end product that accumulates in vivo, along with its glycation-specific precursor hexitol-lysine, are increased in neurons from cases of Alzheimer's disease, especially those containing intracellular neurofibrillary pathology. The increase in hexitol-lysine and CML can result from either lipid peroxidation or advanced glycation, whereas hexitol-lysine is solely a product of glycation, suggesting that two distinct oxidative processes act in concert in the neuropathology of the disease. Furthermore, using olfactory neurons as an experimental model, we observed an increase in glycation products in neurons derived from Alzheimer's disease patients. Our findings support the idea that aldehyde-mediated modifications, in concert with oxyradical-mediated modifications, are critical early pathogenic factors in Alzheimer's disease.
引用
收藏
页码:545 / 552
页数:8
相关论文
共 50 条
[41]   RADICAL AGING IN ALZHEIMERS-DISEASE [J].
SMITH, MA ;
SAYRE, LM ;
MONNIER, VM ;
PERRY, G .
TRENDS IN NEUROSCIENCES, 1995, 18 (04) :172-176
[42]  
SMITH MA, 1994, AM J PATHOL, V145, P42
[43]   ABNORMAL TAU-REACTIVE FILAMENTS IN OLFACTORY MUCOSA IN BIOPSY SPECIMENS OF PATIENTS WITH PROBABLE ALZHEIMERS-DISEASE [J].
TABATON, M ;
CAMMARATA, S ;
MANCARDI, GL ;
CORDONE, G ;
PERRY, G ;
LOEB, C .
NEUROLOGY, 1991, 41 (03) :391-394
[44]   PATHOLOGICAL-CHANGES IN OLFACTORY NEURONS IN PATIENTS WITH ALZHEIMERS-DISEASE [J].
TALAMO, BR ;
RUDEL, RA ;
KOSIK, KS ;
LEE, VMY ;
NEFF, S ;
ADELMAN, L ;
KAUER, JS .
NATURE, 1989, 337 (6209) :736-739
[45]   Advanced glycation endproducts - Associated parameters in the peripheral blood of patients with Alzheimer's disease [J].
Thome, J ;
Munch, G ;
Muller, R ;
Schinzel, R ;
Kornhuber, J ;
BlumDegen, D ;
Sitzmann, L ;
Rosler, M ;
Heidland, A ;
Riederer, P .
LIFE SCIENCES, 1996, 59 (08) :679-685
[46]   HUMAN OLFACTORY EPITHELIUM IN NORMAL AGING, ALZHEIMERS-DISEASE, AND OTHER NEURODEGENERATIVE DISORDERS [J].
TROJANOWSKI, JQ ;
NEWMAN, PD ;
HILL, WD ;
LEE, VMY .
JOURNAL OF COMPARATIVE NEUROLOGY, 1991, 310 (03) :365-376
[47]   ADVANCED GLYCATION END-PRODUCTS CONTRIBUTE TO AMYLOIDOSIS IN ALZHEIMER-DISEASE [J].
VITEK, MP ;
BHATTACHARYA, K ;
GLENDENING, JM ;
STOPA, E ;
VLASSARA, H ;
BUCALA, R ;
MANOGUE, K ;
CERAMI, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) :4766-4770
[48]   HIGH-AFFINITY-RECEPTOR-MEDIATED UPTAKE AND DEGRADATION OF GLUCOSE-MODIFIED PROTEINS - A POTENTIAL MECHANISM FOR THE REMOVAL OF SENESCENT MACROMOLECULES [J].
VLASSARA, H ;
BROWNLEE, M ;
CERAMI, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (17) :5588-5592
[49]  
VLASSARA H, 1994, LAB INVEST, V70, P138
[50]   Oxidative stress signalling in Alzheimer's disease [J].
Zhu, XW ;
Raina, AK ;
Lee, HG ;
Casadesus, G ;
Smith, MA ;
Perry, G .
BRAIN RESEARCH, 2004, 1000 (1-2) :32-39